Outsourcing STREAM
-
Proactive Drug Development: Explained
1/30/2023
Watch this short video to learn about Proactive Drug Development with Altasciences.
-
A Different Kind Of CRO
1/30/2023
Altasciences is an award-winning, forward-thinking, mid-size early phase contract research organization, in Canada and the U.S., offering biopharmaceutical companies of all sizes a proven, flexible approach to early drug development.
-
Flipping The Drug Development Industry On Its Head
6/18/2024
The video dives into the obstacles of the traditional outsourcing relationship between CROs and sponsors, and how Altasciences has broken from tradition to offer an alternative model.
-
The Heart Of The Matter: Early Vs. Late QT Prolongation Testing
2/8/2023
Dr. Beatrice Setnik, Altasciences' Chief Scientific Officer, walks through the differences between early and late QT prolongation testing.
-
Altasciences Has You Covered From Coast To Coast
1/30/2023
With your success in mind, we designed an integrated early phase drug development offering with eight locations, to get you from lead candidate selection to clinical proof of concept, and beyond.
-
How To Take Advantage Of Early Access Programs For The EU
6/12/2024
Learn how to leverage Early Access Programs (EAPs) in the EU to expedite market entry for innovative life science products. Gain insights into running successful EAPs, including crucial steps for France.
-
How Sponsors Turn Disclosure As A Service Into A Strategic Advantage
5/18/2020
In this panel discussion, Teva and Lung Biotechnology disclosure experts discuss why they opted for disclosure as a service. They will detail how it helps them safeguard regulatory compliance and mitigate risk.
-
2024 Market Trends Survey Results: 5 Clinical Trial Trends To Watch
1/23/2025
This insightful roundtable discussion delves into the findings from Greenphire’s 2024 Market Trends Survey. Experts uncover the key challenges and priorities shaping clinical trials in 2025.
-
Streamlining Patient Access To Cell And Gene Therapies
12/21/2023
Learn about the obstacles patients encounter when seeking CGTs and explore how technology and patient services can empower manufacturers and clinical teams to help patients overcome barriers.
-
How CROs Can Reduce Costs, Drive Retention And Become CRO Of Choice
1/17/2024
In this inaugural Phireside webinar of 2024, speakers delve into the pivotal areas where CROs can enhance efficiency and cost-effectiveness.